204 related articles for article (PubMed ID: 29891493)
1. The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis.
Cheng TT; Lai HM; Yu SF; Chiu WC; Hsu CY; Chen JF; Chen YC
J Investig Med; 2018 Aug; 66(6):1004-1007. PubMed ID: 29891493
[TBL] [Abstract][Full Text] [Related]
2. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture.
Cheng TT; Yu SF; Su FM; Chen YC; Su BY; Chiu WC; Hsu CY; Chen JF; Ko CH; Lai HM
Arthritis Res Ther; 2018 Jan; 20(1):16. PubMed ID: 29382355
[TBL] [Abstract][Full Text] [Related]
3. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?
van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
Clin Exp Rheumatol; 2003; 21(2):155-60. PubMed ID: 12747268
[TBL] [Abstract][Full Text] [Related]
4. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
5. Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial.
Shin K; Park SH; Park W; Baek HJ; Lee YJ; Kang SW; Choe JY; Yoo WH; Park YB; Song JS; Lee SG; Yoo B; Yoo DH; Song YW
Clin Ther; 2017 Feb; 39(2):268-278.e2. PubMed ID: 28161119
[TBL] [Abstract][Full Text] [Related]
6. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials.
Blavnsfeldt AG; de Thurah A; Thomsen MD; Tarp S; Langdahl B; Hauge EM
Bone; 2018 Sep; 114():172-180. PubMed ID: 29913256
[TBL] [Abstract][Full Text] [Related]
7. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for bone mineral density changes in patients with rheumatoid arthritis and fracture risk assessment].
Wang Y; Hao YJ; Deng XR; Li GT; Geng Y; Zhao J; Zhou W; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):781-6. PubMed ID: 26474615
[TBL] [Abstract][Full Text] [Related]
9. Management of osteoporosis in rheumatoid arthritis patients.
Hoes JN; Bultink IE; Lems WF
Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
[TBL] [Abstract][Full Text] [Related]
10. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
Wang Y; Zhao R; Gu Z; Dong C; Guo G; Li L
Osteoporos Int; 2020 Aug; 31(8):1401-1409. PubMed ID: 32291467
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
Ma CC; Xu SQ; Gong X; Wu Y; Qi S; Liu W; Xu JH
Arch Osteoporos; 2017 Dec; 12(1):33. PubMed ID: 28374332
[TBL] [Abstract][Full Text] [Related]
13. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
Phuan-Udom R; Lektrakul N; Katchamart W
Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
Matsuno H
Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
Silva RG; Pippa MG; Zerbin CA
Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
[TBL] [Abstract][Full Text] [Related]
16. Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables.
Ørstavik RE; Haugeberg G; Uhlig T; Mowinckel P; Falch JA; Halse JI; Kvien TK
Ann Rheum Dis; 2004 Feb; 63(2):177-82. PubMed ID: 14722207
[TBL] [Abstract][Full Text] [Related]
17. [Identification of bone mass and bone turnover in patients with rheumatoid arthritis treated with corticosteroids in order to elaborate an optimal therapeutic approach].
Macovei L; Ancuţa C; Pomîrleanu C; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):470-6. PubMed ID: 23077939
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids.
Ghazi M; Kolta S; Briot K; Fechtenbaum J; Paternotte S; Roux C
Osteoporos Int; 2012 Feb; 23(2):581-7. PubMed ID: 21350894
[TBL] [Abstract][Full Text] [Related]
19. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis.
Kim D; Cho SK; Kim JY; Choi YY; Sung YK
Mod Rheumatol; 2016 Jul; 26(4):540-5. PubMed ID: 26418481
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
Rheumatology (Oxford); 2022 Apr; 61(4):1448-1458. PubMed ID: 34255815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
